Table 1 Demographic and clinical features
|  | UFSH (n = 86) | TCGA (n = 49) | ||||||
|---|---|---|---|---|---|---|---|---|
HCV-HCC (n = 11) | EtOH-HCC (n = 11) | HCV-cirrhosis (n = 10) | EtOH-cirrhosis (n = 10) | Normal liver (n = 44) | HCV-HCC (n = 20) | EtOH-HCC (n = 20) | Non-cancerous Liver (n = 9) | |
Age [mean (SD)] | 57.6 (7.2) | 64.5 (7.5) | 54.2 (5.4) | 63.0 (6.8) | 57.7 (16.0) | 59.7 (11.2) | 68. 4 (6.6) | 70.3 (11.4) |
p value1 | 0.20 | |||||||
Sex [Freq. (%)] | ||||||||
 Female | 2 (18.2) | 2 (18.2) | 2 (20.0) | 1 (10.0) | 19 (43.2) | 4 (20.0) | 3 (15.0) | 5 (55.6) |
 Male | 9 (81.8) | 9 (81.8) | 8 (80.0) | 9 (90.0) | 25 (56.8) | 16 (80.0) | 17 (85.0) | 4 (44.4) |
p value1 | 0.99 | |||||||
Tumor stage [Freq. (%)] | ||||||||
 I | 3 (27.27) | 3 (27.27) | – | – | – | 9 (45.0) | 9 (45.0) | – |
 II | 4 (36.36) | 2 (18.18) | – | – | – | 5 (25.0) | 4 (20.0) | – |
 III | 3 (27.27) | 4 (36.36) | – | – | – | 4 (20.0) | 5 (25.0) | – |
 Unknown | 1 (9.09) | 2 (18.18) | – | – | – | 2 (10.0) | 2 (10.0) | – |
p value1 | 0.48 | |||||||